Register now to our Newsletter

* indicates required







Our latest news

New IHC platform is now available at TransCure

TransCure presents its new IHC platform.

Three employees join TransCure bioServices team.

TransCure bioServices hires 3 new employees.
BMS and Viiv published efficacy data using TransCure’s full human immune system hu-mouse models

TransCure bioServices involved in BMS and Viiv results

BMS and Viiv published in vivo efficacy data on a new anti-HIV treatment using our Advanced Human Immune System Mouse Models.
The talk about us in the press: LaBiotech

They talk about us in Labiotech – Vaccine/Immunization

Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.
#SUMMERTIME by TransCure bioServices

#SUMMERTIME by TransCure bioServices

A friendly day on Lake Leman for the TransCure bioServices team!
Acquisition of the Newton 7.0 Bioluminescence imaging system

Acquisition of the Newton 7.0 Bioluminescence imaging system

The NEWTON bioluminescence imaging system allows for the non-invasive detection and quantification from the onset throughout full development of any tumor.
Promising HIV Cure demonstrated using CD34+ hu-mouse

Promising Cure against HIV demonstrated using CD34+ human immune system mouse models!

Demonstration of viral clearance targeting latent infectious reservoirs in HIV-1 infected CD34+ human immune system mice treated with LASER ART and CRISPR-Cas9 is available.
Interview of our CEO, Patrick NEF, for the TV channel 8 Mont-Blanc.

Watch the interview of our CEO, Patrick NEF, for the TV channel 8 Mont-Blanc.

Patrick NEF gives a global presentation about TransCure bioServices SAS during an interview for the TV channel 8 Mont-Blanc
Transcure hires Hélène DELPECH

Hélène DELPECH, new Research Engineer, has been hired by TransCure bioServices

TransCure bioServices hires Hélène DELPECH - New Research Engineer

Share this!